Table 2.
Microinjected solution | n injected for in-vitro development | % follicles developed to stages 12–14 |
n. i. | 8 | 88 |
H2O dest. | 45 | 70 |
NIS | 20 | 55 |
AInx2Rb-CT(KLRH) | 50 | 24* |
AInx2GP-CL | 11 | 27* |
AInx4Rb-CT | 14 | 50 |
*, significantly different from NIS (P < 0.05); n, number of injected stage-10b follicles; for further details, see text